Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Inhibiting Cell Death in Lung Endothelium during ARDS by Ultrasound-mediated shRNA delivery
EF 2022-23
Résumé
Acute respiratory distress syndrome (ARDS) is a life-threatening condition that is characterized by flooding of the lung and rapidly decreasing oxygen levels in the blood. Mortality rates can be as high as 40% of cases and there is currently no cure for this condition – as such, there is a strong need to improve the methods of treating established lung injury and reducing mortality in these patients.
ARDS develops due to the loss of the endothelial cell barrier in the lung capillaries after a bacterial or viral infection. The endothelium normally forms a tight barrier along the inside of blood vessels, and the death of these cells creates gaps that allow fluid to leak from the bloodstream into the alveoli of the lungs. The accumulation of fluid impairs gas exchange, decreasing the amount of oxygen entering the blood. There are three main cellular death pathways that have been associated with the endothelium in the context of ARDS: apoptosis, necroptosis, and pyroptosis. We believe that blocking these pathways will stop the death of endothelial cells in the lung capillaries, which will reduce the amount of fluid entering the lung and improve the outcome of ARDS.
To investigate this, we will use an approach previously established in our lab that allows targeted, specific delivery of genes to the injured lung tissue. In a mouse model of ARDS we will inhibit key proteins in the apoptosis, necroptosis, and pyroptosis pathways and assess any benefit or improved survival. This study will lay the groundwork for a new potential method of treating ARDS and reducing patient mortality.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486392
Name
Haas Sahara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Inhibiting Cell Death in Lung Endothelium during ARDS by Ultrasound-mediated shRNA delivery
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ards; Cell Death; Endothelium; Lung Injury; Microbubbles; Ultrasound
Abstract
Acute respiratory distress syndrome (ARDS) is a life-threatening condition that is characterized by flooding of the lung and rapidly decreasing oxygen levels in the blood. Mortality rates can be as high as 40% of cases and there is currently no cure for this condition – as such, there is a strong need to improve the methods of treating established lung injury and reducing mortality in these patients.
ARDS develops due to the loss of the endothelial cell barrier in the lung capillaries after a bacterial or viral infection. The endothelium normally forms a tight barrier along the inside of blood vessels, and the death of these cells creates gaps that allow fluid to leak from the bloodstream into the alveoli of the lungs. The accumulation of fluid impairs gas exchange, decreasing the amount of oxygen entering the blood. There are three main cellular death pathways that have been associated with the endothelium in the context of ARDS: apoptosis, necroptosis, and pyroptosis. We believe that blocking these pathways will stop the death of endothelial cells in the lung capillaries, which will reduce the amount of fluid entering the lung and improve the outcome of ARDS.
To investigate this, we will use an approach previously established in our lab that allows targeted, specific delivery of genes to the injured lung tissue. In a mouse model of ARDS we will inhibit key proteins in the apoptosis, necroptosis, and pyroptosis pathways and assess any benefit or improved survival. This study will lay the groundwork for a new potential method of treating ARDS and reducing patient mortality.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Haas, Sahara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~